Pulsed Field Ablation Versus Radiofrequency Ablation for Persistent Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 700 participants.

Also called NCT06791629

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 700 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06791629
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06791629. Randomized; no masking; primary purpose treatment. Start 2025-02-15 (anticipated); primary completion 2026-12-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pulsed Field Ablation Versus Radiofrequency Ablation for Persistent Atrial Fibrillation
Acronym
PRAISE
Condition
Persistent Atrial Fibrillation
Condition
Radiofrequency Catheter Ablation
Condition
Pulsed Field Ablation
Intervention (Device)
Pulsed Field Ablation
Intervention (Device)
Radiofrequency Ablation
Lead sponsor
Beijing Anzhen Hospital (class: other)

Record details

Record id
cardio:ct-nct06791629
Content hash
cdc7ec2896d152f73738084bf4b044722ee986c3efffecbaf5937720bbe8222a